Effect of metformin on olanzapine-induced weight gain: A 12-week randomised open-label study
Background: Olanzapine is an atypical antipsychotic used in schizophrenia and bipolar affective disorder, but it is associated with weight gain and metabolic syndrome. Metformin is known to decrease insulin resistance and abnormal glucose metabolism. Therefore, it is thought that metformin might pro...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Series: | Journal of Clinical Sciences |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/jcls.jcls_62_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|